Monte Rosa Therapeutics | 4:持股变动声明-董事 Hughes Eric A
Monte Rosa Therapeutics | 3:首次持股声明-董事 Hughes Eric A
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.8%)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(8.312%),Abigail P. Johnson(8.312%)
Monte Rosa Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%)等
Monte Rosa Therapeutics | 4:持股变动声明-股东 Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Versant Venture Capital VI, L.P.(8.3%),Versant Ventures VI GP, L.P.(8.3%)等
Monte Rosa Therapeutics | 4:持股变动声明-股东 Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | 4:持股变动声明-股东 Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics | 4:持股变动声明-高管 Janku Filip
Monte Rosa Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Ali Behbahani(12.7%),New Enterprise Associates 17, L.P.(12.5%)等
Monte Rosa Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Versant Venture Capital VI, L.P.(11.1%),Versant Ventures VI GP, L.P.(11.1%)等
Monte Rosa Therapeutics | 4:持股变动声明-高管 Dunn Edmund
Monte Rosa Therapeutics | 4:持股变动声明-董事 Behbahani Ali
Monte Rosa Therapeutics | 4:持股变动声明-董事 Manning Anthony M.
Monte Rosa Therapeutics | 4:持股变动声明-董事 Blackwell Kimberly
Monte Rosa Therapeutics | 4:持股变动声明-董事 SCHIFF ANDREW N
Monte Rosa Therapeutics | 4:持股变动声明-董事 Skvarka Jan
Monte Rosa Therapeutics | 4:持股变动声明-高管 Nickson Philip
Monte Rosa Therapeutics | 4:持股变动声明-高管 Dunn Edmund
暂无数据